(CAG) ConAgra Foods - Ratings and Ratios
FrozenFood, Snacks, RefrigeratedFood, GroceryProducts, FoodserviceProducts
CAG EPS (Earnings per Share)
CAG Revenue
Description: CAG ConAgra Foods
ConAgra Foods Inc (NYSE:CAG) is a leading consumer packaged goods food company in the United States, operating through four key segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. The companys diverse portfolio includes well-known brands such as Birds Eye, Marie Callenders, and Slim Jim, catering to various retail and foodservice channels.
From a strategic perspective, ConAgras business model is focused on delivering value through its branded products, with a strong presence in the US market and a growing international footprint. The companys ability to innovate and adapt to changing consumer preferences is crucial, given the competitive landscape of the packaged foods industry. Key performance indicators (KPIs) to watch include revenue growth, gross margin expansion, and operating cash flow generation, which can indicate the companys ability to invest in growth initiatives and return value to shareholders.
Analyzing ConAgras financials, we can observe that the company has a market capitalization of approximately $9.3 billion, with a forward P/E ratio of 10.63, suggesting a relatively reasonable valuation compared to its expected earnings growth. The return on equity (RoE) of 13.09% indicates a decent level of profitability, although this should be evaluated in the context of the companys leverage and industry benchmarks. Other relevant KPIs include the debt-to-equity ratio, interest coverage, and dividend yield, which can provide further insights into ConAgras financial health and shareholder returns.
To further evaluate ConAgras investment potential, its essential to assess its competitive positioning, brand strength, and innovation pipeline. The companys ability to drive growth through new product development, strategic acquisitions, and effective marketing initiatives will be critical in maintaining its market share and expanding its customer base. By monitoring KPIs such as brand sales growth, market share trends, and product innovation metrics, investors can gain a deeper understanding of ConAgras long-term prospects and potential for value creation.
CAG Stock Overview
| Market Cap in USD | 9,239m |
| Sub-Industry | Packaged Foods & Meats |
| IPO / Inception | 1984-09-07 |
CAG Stock Ratings
| Growth Rating | -67.4% |
| Fundamental | 59.6% |
| Dividend Rating | 78.2% |
| Return 12m vs S&P 500 | -44.2% |
| Analyst Rating | 3.16 of 5 |
CAG Dividends
| Dividend Yield 12m | 6.37% |
| Yield on Cost 5y | 4.51% |
| Annual Growth 5y | 8.90% |
| Payout Consistency | 97.7% |
| Payout Ratio | 60.9% |
CAG Growth Ratios
| Growth Correlation 3m | -70.3% |
| Growth Correlation 12m | -95.2% |
| Growth Correlation 5y | -54.5% |
| CAGR 5y | -9.25% |
| CAGR/Max DD 5y | -0.19 |
| Sharpe Ratio 12m | -0.74 |
| Alpha | -37.77 |
| Beta | -0.167 |
| Volatility | 23.42% |
| Current Volume | 8268.5k |
| Average Volume 20d | 9649k |
| Stop Loss | 18.5 (-3.3%) |
| Signal | 1.31 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (1.15b TTM) > 0 and > 6% of Revenue (6% = 696.8m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA -1.58pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -10.73% (prev -0.77%; Δ -9.96pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.69b > Net Income 1.15b (YES >=105%, WARN >=100%) |
| Net Debt (8.24b) to EBITDA (1.96b) ratio: 4.19 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.71 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (478.2m) change vs 12m ago -0.13% (target <= -2.0% for YES) |
| Gross Margin 25.86% (prev 27.66%; Δ -1.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 55.57% (prev 57.76%; Δ -2.20pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.76 (EBITDA TTM 1.96b / Interest Expense TTM 418.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.02
| (A) -0.06 = (Total Current Assets 3.07b - Total Current Liabilities 4.32b) / Total Assets 20.93b |
| (B) 0.32 = Retained Earnings (Balance) 6.76b / Total Assets 20.93b |
| (C) 0.08 = EBIT TTM 1.57b / Avg Total Assets 20.90b |
| (D) 0.81 = Book Value of Equity 9.70b / Total Liabilities 12.00b |
| Total Rating: 2.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.56
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 7.54% = 3.77 |
| 3. FCF Margin 11.22% = 2.80 |
| 4. Debt/Equity 0.91 = 2.10 |
| 5. Debt/Ebitda 4.13 = -2.50 |
| 6. ROIC - WACC 5.68% = 7.10 |
| 7. RoE 13.09% = 1.09 |
| 8. Rev. Trend -43.60% = -2.18 |
| 9. Rev. CAGR -1.55% = -0.26 |
| 10. EPS Trend -51.94% = -1.30 |
| 11. EPS CAGR -0.64% = -0.08 |
What is the price of CAG shares?
Over the past week, the price has changed by -2.70%, over one month by +0.53%, over three months by -14.06% and over the past year by -34.67%.
Is ConAgra Foods a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CAG is around 17.49 USD . This means that CAG is currently overvalued and has a potential downside of -8.57%.
Is CAG a buy, sell or hold?
- Strong Buy: 0
- Buy: 3
- Hold: 16
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CAG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.1 | 10.5% |
| Analysts Target Price | 26.7 | 39.4% |
| ValueRay Target Price | 18.6 | -2.7% |
Last update: 2025-08-23 04:34
CAG Fundamental Data Overview
CCE Cash And Equivalents = 68.0m USD (last quarter)
P/E Trailing = 8.0417
P/E Forward = 10.9051
P/S = 0.7956
P/B = 1.0316
P/EG = 12.1184
Beta = 0.077
Revenue TTM = 11.61b USD
EBIT TTM = 1.57b USD
EBITDA TTM = 1.96b USD
Long Term Debt = 6.23b USD (from longTermDebt, last quarter)
Short Term Debt = 1.87b USD (from shortTermDebt, last quarter)
Debt = 8.11b USD (Calculated: Short Term 1.87b + Long Term 6.23b)
Net Debt = 8.24b USD (from netDebt column, last quarter)
Enterprise Value = 17.28b USD (9.24b + Debt 8.11b - CCE 68.0m)
Interest Coverage Ratio = 3.76 (Ebit TTM 1.57b / Interest Expense TTM 418.6m)
FCF Yield = 7.54% (FCF TTM 1.30b / Enterprise Value 17.28b)
FCF Margin = 11.22% (FCF TTM 1.30b / Revenue TTM 11.61b)
Net Margin = 9.92% (Net Income TTM 1.15b / Revenue TTM 11.61b)
Gross Margin = 25.86% ((Revenue TTM 11.61b - Cost of Revenue TTM 8.61b) / Revenue TTM)
Tobins Q-Ratio = 1.78 (Enterprise Value 17.28b / Book Value Of Equity 9.70b)
Interest Expense / Debt = 1.26% (Interest Expense 101.8m / Debt 8.11b)
Taxrate = 0.32% (from yearly Income Tax Expense: 3.70m / 1.16b)
NOPAT = 1.57b (EBIT 1.57b * (1 - 0.32%))
Current Ratio = 0.71 (Total Current Assets 3.07b / Total Current Liabilities 4.32b)
Debt / Equity = 0.91 (Debt 8.11b / last Quarter total Stockholder Equity 8.93b)
Debt / EBITDA = 4.13 (Net Debt 8.24b / EBITDA 1.96b)
Debt / FCF = 6.22 (Debt 8.11b / FCF TTM 1.30b)
Total Stockholder Equity = 8.80b (last 4 quarters mean)
RoA = 5.50% (Net Income 1.15b, Total Assets 20.93b )
RoE = 13.09% (Net Income TTM 1.15b / Total Stockholder Equity 8.80b)
RoCE = 10.47% (Ebit 1.57b / (Equity 8.80b + L.T.Debt 6.23b))
RoIC = 9.14% (NOPAT 1.57b / Invested Capital 17.16b)
WACC = 3.46% (E(9.24b)/V(17.35b) * Re(5.40%)) + (D(8.11b)/V(17.35b) * Rd(1.26%) * (1-Tc(0.00)))
Shares Correlation 5-Years: -100.0 | Cagr: -0.19%
Discount Rate = 5.40% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 79.86% ; FCFE base≈1.43b ; Y1≈1.61b ; Y5≈2.14b
Fair Price DCF = 77.57 (DCF Value 37.13b / Shares Outstanding 478.7m; 5y FCF grow 14.02% → 3.0% )
Revenue Correlation: -43.60 | Revenue CAGR: -1.55%
Rev Growth-of-Growth: -2.12
EPS Correlation: -51.94 | EPS CAGR: -0.64%
EPS Growth-of-Growth: -11.52
Additional Sources for CAG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle